Systemic amyloidosis from transthyretin (ATTR) protein is increasingly recognized as an important cause of heart failure in older people. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses the diagnosis and treatment of ATTR protein cardiomyopathy with Frederick L. Ruberg, MD, of the Boston University Chobanian & Avedisian School of Medicine.
Related Content:
USPSTF Recommendation: Screening for Breast Cancer
Diagnosis and Treatment of Interstitial Lung Disease
Clinical Diagnosis of Dislocated Hips in Newborns
Diagnosis and Treatment of Systemic Lupus Erythematosus
Falls in Community-Dwelling Older Adults
Diagnoses and Treatment of Common Oral Conditions
USPSTF Recommendation: Primary Care Interventions to Prevent Child Maltreatment
Arteriovenous Access for Hemodialysis
Diagnosis and Treatment of Allergic Rhinitis
Long-Term Outcomes After Bariatric Surgery for Type 2 Diabetes
Diagnosis and Management of Paroxysmal Supraventricular Tachycardia
Prevention and Treatment of Severe Food Allergies
Climate Change and Health: A New JAMA Series
Thyroid Cancer
USPSTF Recommendation: Screening for Speech and Language Delay and Disorders
How Artificial Intelligence Has Evolved and the Implications for Health Care
Age-Related Macular Degeneration
JAMA Editors’ Choice 2023: Clinical Reviews Podcasts
Postpartum Depression
Create your
podcast in
minutes
It is Free
JAMA Editors’ Summary
JAMA Medical News
JAMAevidence The Rational Clinical Examination
JAMA Psychiatry Author Interviews
JAMA Internal Medicine Author Interviews